Sedative and hypnotic effects of Schisandrin B through increasing GABA/Glu ratio and upregulating the expression of GABAA in mice and rats - 29/05/18
pages | 8 |
Iconographies | 10 |
Vidéos | 0 |
Autres | 0 |
Graphical abstract |
Abstract |
Schisandrin B (SchB) is an active lignan component from Schisandra chinensis Turcz. Baill that has been long used as Traditional Chinese Medical Herb in the prescriptions for “tranquilizing the mind and overcoming anxiety”. Given that SchB is one of the most abundant ingredients of Schisandra chinensis Baill, we examined the sedative and hypnotic effects of SchB and explored the underlying mechanism. The results showed that SchB can significantly decrease mouse locomotor activities and improved sleeping quality index, including increased number of sleeping mice treated with the subthreshold dose of pentobarbital sodium, increased sleep time, shortened sleep latency and prolonged sleep duration. We found that SchB could significantly elevate the level of γ-aminobutyric acid (GABA) and reduce the level of glutamic acid(Glu)in the peripheral blood of mice as well as in the cerebral cortex, hippocampus, hypothalamus of rats, resulting in the increased ratio of GABA/Glu. GABA receptor inhibitor picrotoxin could antagonize the effect of SchB on the sleep latency and duration in the mice treated with the threshold dose of pentobarbital sodium. Furthermore, SchB up-regulates the expression of GABAA Rα1 and GABAA Rγ2 genes in the cerebral cortex, hippocampus and hypothalamus. In conclusion, SchB is the active component in Schisandra chinensis Baill responsible for the sedative and hypnotic function through up-regulating the expression of GABAA receptors and modulating the content of GABA and Glu in the peripheral blood and brain tissues.
Le texte complet de cet article est disponible en PDF.Keywords : Schisandrin B (SchB), Sedation and hypnosis, Neurotransmitter
Plan
Vol 103
P. 509-516 - juillet 2018 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’achat d’article à l’unité est indisponible à l’heure actuelle.
Déjà abonné à cette revue ?